Join expert faculty as they discuss part one of what you need to know about obesity and newer treatment options. This episode touches on lifestyle modifications, chronicity of obesity medications, adverse effects and drug interactions, cost and access of these medications, and more!
SPEAKERS
Jennifer N. Clements, PharmD is a Clinical Professor and Director of Pharmacy Education with the University of South Carolina College of Pharmacy at the School of Medicine – Greenville Campus. Dr. Clements earned her Pharm.D. from Campbell University in 2006 and completed a primary care pharmacy practice residency in 2007 at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. She is a board-certified pharmacotherapy specialist, board-certified ambulatory care pharmacist, certified diabetes care and education specialist, and board certified in advanced diabetes management. Dr. Clements has authored numerous publications and presentations related to diabetes and obesity pharmacotherapy.
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an Endocrinology Clinical Pharmacy Specialist. She serves as the Co-Director of Endocrine Disorders in Pregnancy and the Director of Education and Training in Diabetes Technology at the Cleveland Clinic Endocrinology and Metabolism Institute. Dr. Isaacs earned her bachelor’s degree in chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville (SIUE) and completed a pharmacy practice residency at the Philadelphia Veterans Affairs. Dr. Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management and is a Certified Diabetes Care and Education Specialist.
Dr. Isaacs served on the American Diabetes Association (ADA) Professional Practice Committee from 2020-2023, the committee that updates the ADA Standards of Care. She also served on the Association of Diabetes Care and Education Specialists (ADCES) Board of Directors from 2021-2024. She is currently on the leadership of the Diabetes Practice Group for the American Association of Clinical Endocrinology. She co-hosts a popular podcast titled “Diabetes Dialogue: Technology, Therapeutics and Real-World Perspectives.” She advocates access and choice to the latest technologies and therapeutics for all people with diabetes and obesity and speaks on related topics nationally and internationally. She was the ADCES Diabetes Care and Education Specialist of the Year in 2020 and inducted into the SIUE Alumni Hall of Fame in 2022 for her far reaching contributions in diabetes care.
Relevant Financial Relationship Disclosures
The following persons in control of this activity’s content have relevant financial relationships:
Jennifer N. Clements: Novo Nordisk – Speaker’s bureau; Xeris Pharmaceuticals – Consultant; Embecta – Advisory board; Lilly – Speaker’s bureau
All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Provided by ASHP. Supported by an educational grant from Novo Nordisk.